50628-74-5 Usage
Derivative of pteridine
10-hydroxybenzo[g]pteridine-2,4(3H,10H)-dione 5-oxide is derived from pteridine, which is a bicyclic heterocyclic compound.
Pteridine 5-oxide
The compound contains an oxygen atom attached to the fifth carbon of the pteridine ring, classifying it as a pteridine 5-oxide.
Widespread presence in nature
Pteridines, including this specific compound, are found in various natural sources and play essential roles in biological processes.
Role in coenzymes and pigments
Pteridines are crucial components of coenzymes and pigments, which are vital for various biological functions.
Potential applications in pharmaceuticals
Due to its unique structure and properties, 10-hydroxybenzo[g]pteridine-2,4(3H,10H)-dione 5-oxide may have possible uses in the pharmaceutical industry.
Potential applications in biochemistry
The compound could be relevant in the field of biochemistry, possibly for studying enzyme mechanisms or other biochemical processes.
Potential applications in materials science
10-hydroxybenzo[g]pteridine-2,4(3H,10H)-dione 5-oxide may also be useful in materials science, potentially for developing new materials with unique properties.
Need for further research
More research and study are required to fully understand the potential uses and effects of this specific pteridine derivative.
Check Digit Verification of cas no
The CAS Registry Mumber 50628-74-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,6,2 and 8 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 50628-74:
(7*5)+(6*0)+(5*6)+(4*2)+(3*8)+(2*7)+(1*4)=115
115 % 10 = 5
So 50628-74-5 is a valid CAS Registry Number.
50628-74-5Relevant academic research and scientific papers
Waly, Mohamed,Elgogary, Sameh,Lashien, Ahmed,Farag, Ahmad
, p. 411 - 417 (2015)
A new series of tricyclic pyrimidoquinoxaline derivatives were synthesized and evaluated as antitumor assays and compared with standard drug 5-fluorouracil. These new pyrimidoquinoxaline derivatives were synthesized by the reaction with o-aminonitrilequinoxaline derivative 3 with various reagents. One from which, the condensation of o-aminonitrile with potassium cyanate in acetic acid was stated as a new procedure for building the pyrimidine ring incorporate to quinoxaline moiety. Further condensation of aminonitrile 3 with formamide or Vilsmeier reaction followed by transamination or carbon disulphide was applied as procedures for the pyrimidine ring syntheses. Compound 15 achieved significant in vitro antitumor activity, and compounds 9 and 14 have high activities.
